Journal article

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk

Celine M Vachon, Christopher G Scott, Rulla M Tamimi, Deborah J Thompson, Peter A Fasching, Jennifer Stone, Melissa C Southey, Stacey Winham, Sara Lindstrom, Jenna Lilyquist, Graham G Giles, Roger L Milne, Robert J MacInnis, Laura Baglietto, Jingmei Li, Kamila Czene, Manjeet K Bolla, Qin Wang, Joe Dennis, Lothar Haeberle Show all

Breast Cancer Research | BMC | Published : 2019

Grants

Awarded by National Cancer Institute


Awarded by Cancer Research UK


Awarded by European Community's Seventh Framework Programme


Awarded by European Union's Horizon 2020 Research and Innovation Programme


Awarded by National Institutes of Health


Awarded by National Research Foundation Singapore Fellowship


Awarded by Australian National Health and Medical Research Council


Funding Acknowledgements

This work was supported by the National Cancer Institute (R01 CA128931, R01 CA122340, R01 CA128978, R01 CA97396, P50 CA116201, R01 CA240386, K24 CA169004, R21 CA179442, P01 CA154292, P01CA87969, R01 CA085265, UM1CA176726, UM1CA186107, and U01 CA164973) and the Breast Cancer Research Foundation. BBCC was supported in part by the ELAN program of the Medical Faculty, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg. Funding for the genotyping of BBCC and MCBCS as well as the iCOGS Illumina array is provided by grants from the EU FP7 programme (COGS) and from Cancer Research UK. Collaborative Oncological Gene-environment Study (COGS) enabled the genotyping for this study. Funding for the BCAC component is provided by grants from the EU FP7 programme (COGS) and from Cancer Research UK. BCAC is funded by Cancer Research UK [C1287/A16563] and by the European Community's Seventh Framework Programme under grant agreement no 223175 (HEALTH-F2-2009-223175) (COGS) and by the European Union's Horizon 2020 Research and Innovation Programme under grant agreements 633784 (B-CAST) and 634935 (BRIDGES). The SASBAC study was supported by the Marit and Hans Rausing's Initiative Against Breast Cancer, the National Institutes of Health (RO1 CA58427), the Agency for Science, Technology and Research (A*STAR; Singapore), and the Swedish Research Council. Jingmei Li is a recipient of a National Research Foundation Singapore Fellowship (NRF-NRFF2017-02). The Melbourne Collaborative Cohort Study (MCCS) cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian National Health and Medical Research Council grants 209057 and 396414 and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry and the Australian Institute of Health and Welfare, including the National Death Index and the Australian Cancer Database.